| |
| |
|
| Insider
Information: |
King Richard |
| Relationship: |
Chief Executive Office... |
| City: |
Miami |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
185,653 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$540,214 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
185,653 |
|
|
| Total
Value |
$540,214 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acelrx Pharmaceuticals Inc |
ACRX |
Director |
2014-03-02 |
134,567 |
2011-03-02 |
0 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
Chief Operating Officer |
2018-06-21 |
48,856 |
2017-05-05 |
0 |
Premium* |
|
|
Spruce Biosciences, Inc. |
SPRB |
Chief Executive Office... |
2021-06-30 |
2,230 |
2021-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SPRB |
Spruce Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-06-30 |
4 |
A |
$9.53 |
$21,249 |
D/D |
2,230 |
2,230 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2018-06-21 |
4 |
S |
$25.48 |
$63,725 |
D/D |
(2,501) |
48,856 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2018-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
50,661 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2018-02-28 |
4 |
A |
$25.07 |
$250,700 |
D/D |
10,000 |
39,661 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
28,125 |
28,125 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2014-03-02 |
4 |
D |
$11.43 |
$132,577 |
D/D |
(11,599) |
134,567 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2011-06-09 |
4 |
B |
$4.56 |
$15,960 |
D/D |
3,500 |
126,957 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
President and CEO |
• • – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
123,457 |
123,457 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
